Biotec Pharmacon ASA (OSL:BIOTEC) Biotec Pharmacon ASA has entered into a new market making agreement for the company`s shares. The agreement is entered into with DnB NOR Markets who undertakes to quote bid- and offer prices in the share for at least 4 round lots and with a maximum spread of 4%. The agreement is based on Oslo Børs` requirements for liquidity provider agreements, and will become effective starting from January 26th, 2009. The agreement replaces the previous market maker agreement with SEB Enskilda.
This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
Biotec Pharmacon ASA
http://www.biotec.no
ISIN: NO0010014632
Stock Identifier: XOSL.BIOTEC
This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
Biotec Pharmacon ASA
http://www.biotec.no
ISIN: NO0010014632
Stock Identifier: XOSL.BIOTEC
| Tweet |
 |
Related Companies |
>>> Fortis |
| |
Related Industry Topics: |
European Finance News | |
| |
Diese Seite wurde besucht: (letzten 7 Tagen: 10) (letzten 30 Tagen: 30) (seit Veröffentlichung: 5610) |
Site Search
| DEUTSCH All Languages |
Upcoming WebCasts
 | Mr Mark Paton CEO Cue Energy Resources Tuesday, June 12, 2012 |
 | Mr Alan Hopkins CEO Pan Asia Corporation Tuesday, June 12, 2012 |
 | Mr Barry Dawes Martin Place Securities Tuesday, June 12, 2012 |
 | Dr Andrea Grant CEO Living Cell Technologies Monday, July 02, 2012 |
|
Fortis | ||||||
|
|||||||
Companies in the News
Mobile Video TV
|
||
|
||
